Open Access

miR‑27b‑3p modulates CD4+CD39+ Tregs to drive immune‑mediated intervertebraldisc degeneration

  • Authors:
    • Qiuwei Li
    • Chenhao Zhao
    • Peilin Jin
    • Cailiang Shen
  • View Affiliations

  • Published online on: September 11, 2025     https://doi.org/10.3892/ijmm.2025.5634
  • Article Number: 193
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Intervertebral disc degeneration (IVDD) is a major cause of chronic back pain, yet its molecular mechanisms remain poorly understood despite its high prevalence. In the present study, the significant role of microRNA (miR)‑27b‑3p in regulating 731 immune cell types was systematically uncovered utilizing Mendelian randomization (MR) and single‑cell RNA sequencing, with a particular focus on CD4+CD39+ regulatory T cells (Tregs); and its critical impact on immune‑mediated IVDD progression was highlighted. A total of 76 miRs were screened and, through MR analysis, a significant causal relationship between miR‑27b‑3p and IVDD was identified. Subsequent in vivo and in vitro experiments demonstrated that miR‑27b‑3p overexpression not only promoted apoptosis of nucleus pulposus cells but also accelerated IVDD by modulating the immune functions of CD4+CD39+ Tregs. Single‑cell RNA sequencing further revealed a marked upregulation of immune‑related genes in degenerated discs, particularly those involved in immune cell migration, inflammation and apoptotic regulation pathways. These findings suggest that miR‑27b‑3p plays a pivotal role in IVDD by influencing various immune cells, especially CD4+CD39+ Tregs, underscoring its potential as a therapeutic target with significant clinical implications. Further research into the mechanisms of miR‑27b‑3p could open new avenues for IVDD treatment strategies, offering promising possibilities for future clinical applications.
View Figures
View References

Related Articles

Journal Cover

November-2025
Volume 56 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Q, Zhao C, Jin P and Shen C: miR‑27b‑3p modulates CD4+CD39+ Tregs to drive immune‑mediated intervertebraldisc degeneration. Int J Mol Med 56: 193, 2025.
APA
Li, Q., Zhao, C., Jin, P., & Shen, C. (2025). miR‑27b‑3p modulates CD4+CD39+ Tregs to drive immune‑mediated intervertebraldisc degeneration. International Journal of Molecular Medicine, 56, 193. https://doi.org/10.3892/ijmm.2025.5634
MLA
Li, Q., Zhao, C., Jin, P., Shen, C."miR‑27b‑3p modulates CD4+CD39+ Tregs to drive immune‑mediated intervertebraldisc degeneration". International Journal of Molecular Medicine 56.5 (2025): 193.
Chicago
Li, Q., Zhao, C., Jin, P., Shen, C."miR‑27b‑3p modulates CD4+CD39+ Tregs to drive immune‑mediated intervertebraldisc degeneration". International Journal of Molecular Medicine 56, no. 5 (2025): 193. https://doi.org/10.3892/ijmm.2025.5634